Seneca Biopharma Inc. (NASDAQ:SNCA) went down by -4.85% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $0.72 to trade ended Tuesday trading at $0.76. This is down from the $0.7567 price recorded on Monday’s trading session. Thanks to this latest performance, SNCA is closer to the higher price 52-week target of $520.00 and further from the lowest price target of $520.00. Its performance from the start of the year has also been negative, with SNCA down by -27.27% year-to-date.
Seneca Biopharma Inc. (SNCA) started the day trading at $0.7567 and recorded an intraday high of $0.7567. It also recorded an intraday low of $0.713 during Tuesday’s trading session. Seneca Biopharma Inc. is a very active stock that recorded a trading volume that is less than -554.06% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 463261, which is less than -554.06 of the total average daily trading volume of 3.03 million.
Seneca Biopharma Inc. (NASDAQ:SNCA) 2020 Performance Impressive
The increase in SNCA’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of SNCA currently stands at $9.89, which is higher than the current trading price of the stock by 92.72%. However, SNCA’s current trading price is -44.0% lower than the 52-week low price of $0.50. In terms of trading volume, Seneca Biopharma Inc. currently experienced healthy participation during the last trading session. 463261 shares of Seneca Biopharma Inc. were traded on the stock exchange on Tuesday, which is less than -554.06% of the 3.03 million average trading volume of the stock.
The performance of the stock has been positive over the past year. SNCA’s performance over the past one year has seen it plunge by -88.00%, while the stock has gone down by -21.74% in the last six months. The quarterly performance of SNCA currently stands at 8.74%, and it is down by -21.93% in the last month. The only negative figure was from the weekly performance, which currently reads -14.29%. At the time of writing SNCA’s report, the company has a total market cap of $12.85M, making it one of the largest publicly-traded companies in the world.Seneca Biopharma Inc. also has over 5 employees all over the world.
SNCA Insider Activities
For Seneca Biopharma Inc., insiders hold 3.20% of all company shares. The insider transactions over the past six months are down by 0.00%. During that period, insiders bought 0 shares in 0 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Seneca Biopharma Inc. now hold 396.82k shares, which is over 7.44% of the total company stocks. Institutional investors currently hold a large chunk of the SNCA shares, as they control 4.21% of the company’s total stock.
SNCA Fundamental Analysis
For Seneca Biopharma Inc., the stock’s diluted earnings per share (EPS) stands at -3.39. The stock’s EPS growth this year is 41.50%, 43.80% in the previous five years. In terms the average annual revenue of 43.80% over the past half a decade.
SNCA Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of SNCA currently stands at -14.34%, while the SMA50 is -12.74%. The biggest one is the SMA200, which is currently reading -28.27% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 38.45.